ZICC Stock Overview
Develops dry powder preparations of biological pharmaceuticals. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Ziccum AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 1.00 |
| 52 Week High | SEK 8.26 |
| 52 Week Low | SEK 0.88 |
| Beta | 1.32 |
| 11 Month Change | -56.70% |
| 3 Month Change | -80.85% |
| 1 Year Change | -84.29% |
| 33 Year Change | -91.67% |
| 5 Year Change | -91.34% |
| Change since IPO | -83.12% |
Recent News & Updates
Recent updates
Shareholder Returns
| ZICC | SE Pharmaceuticals | SE Market | |
|---|---|---|---|
| 7D | -46.6% | -6.8% | -2.1% |
| 1Y | -84.3% | 8.0% | 10.8% |
Return vs Industry: ZICC underperformed the Swedish Pharmaceuticals industry which returned 8% over the past year.
Return vs Market: ZICC underperformed the Swedish Market which returned 10.8% over the past year.
Price Volatility
| ZICC volatility | |
|---|---|
| ZICC Average Weekly Movement | 19.0% |
| Pharmaceuticals Industry Average Movement | 10.8% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 11.2% |
| 10% least volatile stocks in SE Market | 3.3% |
Stable Share Price: ZICC's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: ZICC's weekly volatility has increased from 13% to 19% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | 10 | Ann Gidner | ziccum.com |
Ziccum AB (publ) develops dry powder preparations of biological pharmaceuticals. It develops and commercializes LaminarPace, a spray drying technology that dries liquid biopharmaceuticals, such as vaccines or protein therapeutics into a particle engineered powder product. The company was incorporated in 2017 and is headquartered in Lund, Sweden.
Ziccum AB (publ) Fundamentals Summary
| ZICC fundamental statistics | |
|---|---|
| Market cap | SEK 16.04m |
| Earnings (TTM) | -SEK 25.18m |
| Revenue (TTM) | SEK 5.76m |
2.8x
P/S Ratio-0.6x
P/E RatioIs ZICC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ZICC income statement (TTM) | |
|---|---|
| Revenue | SEK 5.76m |
| Cost of Revenue | SEK 0 |
| Gross Profit | SEK 5.76m |
| Other Expenses | SEK 30.94m |
| Earnings | -SEK 25.18m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 29, 2025
| Earnings per share (EPS) | -1.58 |
| Gross Margin | 100.00% |
| Net Profit Margin | -437.13% |
| Debt/Equity Ratio | 17.0% |
How did ZICC perform over the long term?
See historical performance and comparison